Copyright 2020 FactSet Research Systems Inc. All rights reserved. Source: FactSet Fundamentals Stocks: Real-time U.S. stock quotes reflect trades reported through ...

Pfizer said its experimental obesity drug, which it acquired through Metsera, drove solid weight loss when taken once a month in a mid-stage trial. The data offer early evidence that the injection can ...

VESPER-3 reinforces confidence in monthly dosing of PF-08653944 (MET-097i), including the potential for higher dosing regimens in Phase 3 Study met primary endpoint of statistically significant weight ...

Attorney General Pam Bondi’s demand that Minnesota hand over sensitive voter registration records to the federal government amid tensions over ICE and immigration enforcement underscores the ...

Gaming and Leisure Properties offers a nearly 7% yield and trades below $45/share, implying over 15% annualized return potential. GLPI's regional, diversified portfolio and triple-net lease structure ...

Using only natural language instructions, researchers were able to bypass Google Gemini's defenses against malicious prompt injection and create misleading events to leak private Calendar data.

Cybersecurity researchers have disclosed details of a security flaw that leverages indirect prompt injection targeting Google Gemini as a way to bypass authorization guardrails and use Google Calendar ...

GLP-1 (glucagon-like peptide-1 receptor agonists) like Ozempic and Wegovy continue to make headlines as more research points to the benefits of taking these medications. Traditionally, patients ...

Microsoft has fixed a vulnerability in its Copilot AI assistant that allowed hackers to pluck a host of sensitive user data with a single click on a legitimate URL. The hackers in this case were white ...

There’s a well-worn pattern in the development of AI chatbots. Researchers discover a vulnerability and exploit it to do something bad. The platform introduces a guardrail that stops the attack from ...

The IPO window may have cracked open, but it seems some former startups have no intention of going public. Makes sense, in a way: IPOs were traditionally a way to raise money, and if you can manage to ...